Phase 1 Neuroblastoma, Recurrent, Refractory Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma

Neuroblastoma (NB)Neuroblastoma, Recurrent, RefractoryNeuroblastoma in Children

Marzieh Ebrahimi10 enrolled1 locationNCT06674265

Recruiting

Phase 1

Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma

Neuroblastoma, Recurrent, Refractory

Nanjing Children's Hospital12 enrolled2 locationsNCT06751134